Signaling pathway switch in breast cancer

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Guille, Arnaud ^a   Chaffanet, Max ^a   Birnbaum, Daniel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Breast cancer; Cell cycle; Kinases; Next generation sequencing; Signaling pathways

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX;

ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL RENEWAL; ENZYME ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 84879448414     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-66     Document Type: Article

References (13)

1. The Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. 10.1038/nature11412, 3465532, 23000897, The Cancer Genome Atlas Network.
2. Shah P, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486:385-399.
3. Banerji S, Cibulskis K, Rangel-Escareno K, Brown KK, Carter SL, Frederick AM, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 2012, 486:405-409. 10.1038/nature11154, 22722202.
4. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012, 486:353-360. 3383766, 22722193.
5. Birnbaum D, Sircoulomb F, Imbert J. A reason why the ERBB2 gene is amplified and not mutated in breast cancer. Cancer Cell Int 2009, 9:5. 10.1186/1475-2867-9-5, 2649042, 19226453.
6. Hynes N, MacDonald G. ErbB receptors and signaling pathways in cancer. Curr Op Cell Biol 2009, 21:177-184. 10.1016/j.ceb.2008.12.010, 19208461.
7. Wu G, Feng X, Lincoln Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biol 2010, 11:R53. 10.1186/gb-2010-11-5-r53, 2898064, 20482850.
8. Oxford KW, Scadden DT. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 2008, 9:115-127. 10.1038/nrg2269, 18202695.
9. Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 2002, 12:432-438. 10.1016/S0962-8924(02)02352-8, 12220864.
10. Cairns RA, Harris IS, Mak TW. Regulation of cancer metabolism. Nat Rev Cancer 2011, 11:85-95.
11. Eijkelenboom A, Burgering BMT. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 2013, 14:83-97.
12. Grunt TW, Mariani GL. Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling. Curr Cancer Drug Targets 2013, 13:188-204. 10.2174/1568009611313020008, 23215720.
13. Eisinger F, Sobol H, Birnbaum D. Hypothesis: more mutations to cure cancer?. Oncol Rep 1999, 6:1189-1190.